Published in Proc Natl Acad Sci U S A on July 01, 1984
Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci U S A (2010) 1.42
Multiple influences of a heparin-binding growth factor on neuronal development. J Cell Biol (1987) 1.40
Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest (1989) 1.10
Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest (1997) 1.03
Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. Proc Natl Acad Sci U S A (1998) 1.01
Immunofluorescence localization of thyroid hormone receptor protein beta 1 and variant alpha 2 in selected tissues: cerebellar Purkinje cells as a model for beta 1 receptor-mediated developmental effects of thyroid hormone in brain. Proc Natl Acad Sci U S A (1991) 0.96
Discovery of growth hormone-releasing hormones and receptors in nonmammalian vertebrates. Proc Natl Acad Sci U S A (2007) 0.87
Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest (1986) 0.86
Growth hormone releasing factor evokes rhythmic hyperpolarizing currents in rat anterior pituitary cells. J Physiol (1988) 0.86
Chemoselective one-step purification method for peptides synthesized by the solid-phase technique. Proc Natl Acad Sci U S A (1991) 0.80
Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol (2015) 0.76
Regulation of growth hormone-releasing hormone gene expression and biosynthesis. Yale J Biol Med (1990) 0.75
Growth hormone releasing factors. J R Soc Med (1987) 0.75
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (1982) 3.10
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides. Anal Biochem (1982) 1.73
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A (1982) 1.66
Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A (1983) 1.57
Characterization of rat hypothalamic growth hormone-releasing factor. Nature (1983) 1.24
Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature (1983) 1.20
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun (1983) 0.99
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun (1983) 0.99
Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem Biophys Res Commun (1982) 0.96
Synthesis of a nonadecapeptide corresponding to residues 37-55 of ovine prolactin. 1 Detection and isolation of the sulfonium form of methionine-containing peptides. J Am Chem Soc (1976) 0.93
Primary structures of three human pancreas peptides with growth hormone-releasing activity. J Biol Chem (1983) 0.93
Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun (1983) 0.88
Ectopic hormone production viewed as an abnormality in regulation of gene expression. Adv Cancer Res (1980) 0.84
A rapid method for the preparation of amino acid resin esters for Merrifield solid-phase peptide synthesis. Biopolymers (1973) 0.82
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (1972) 11.71
Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys (1973) 7.81
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature (1992) 7.02
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun (1992) 5.31
A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster. Cell (1988) 4.67
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A (1985) 4.60
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature (1984) 4.27
Common precursor to corticotropins and endorphins. Proc Natl Acad Sci U S A (1977) 3.99
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A (1987) 3.88
Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A (1986) 3.42
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (1982) 3.10
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (1977) 2.68
Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev (1998) 2.55
Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50
Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature (1986) 2.37
Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J Cell Biol (1997) 2.35
Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun (1985) 2.33
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
[Endorphins, hypothalamic and neurohypophysial peptides with morphinomimetic activity: isolation and molecular structure of alpha-endorphin]. C R Acad Sci Hebd Seances Acad Sci D (1976) 2.22
Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature (1986) 2.17
gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem (1977) 2.13
Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology (1972) 2.09
Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun (1987) 2.08
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature (1993) 2.03
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc Natl Acad Sci U S A (1978) 1.98
Receptor- and heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1988) 1.87
Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun (1986) 1.86
Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science (1988) 1.84
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci U S A (1986) 1.82
Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. Proc Natl Acad Sci U S A (1976) 1.80
beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proc Natl Acad Sci U S A (1976) 1.79
Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. Proc Natl Acad Sci U S A (1976) 1.76
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proc Natl Acad Sci U S A (1977) 1.74
High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides. Anal Biochem (1982) 1.73
Purification of kidney epithelial cell growth inhibitors. Proc Natl Acad Sci U S A (1980) 1.73
Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (1995) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Somatostatin. Recent Prog Horm Res (1975) 1.67
Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. J Clin Endocrinol Metab (1970) 1.67
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A (1982) 1.66
Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab (1982) 1.64
The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. J Neurochem (1977) 1.63
Role of the central melanocortin system in cachexia. Cancer Res (2001) 1.60
Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A (1983) 1.57
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A (1972) 1.57
Radioimmunoassays for alpha-endorphin and beta-endorphin. Biochem Biophys Res Commun (1977) 1.55
Plant response traits mediate the effects of subalpine grasslands on soil moisture. New Phytol (2008) 1.55
Two distinct mechanisms for ornithine decarboxylase regulation by polyamines in rat hepatoma cells. J Cell Physiol (1979) 1.55
Molecular cloning of the rat integrin alpha 1-subunit: a receptor for laminin and collagen. J Cell Biol (1990) 1.54
[Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-NH2 sequence]. C R Acad Sci Hebd Seances Acad Sci D (1969) 1.54
Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature (1977) 1.54
Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci U S A (1985) 1.54
Peptides in the brain: the new endocrinology of the neuron. Science (1978) 1.51
Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature (1975) 1.50
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science (1976) 1.50
Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem (1993) 1.44